Oral Anticoagulant Therapy: Quality-of-Life Issues

Seminars in Vascular Medicine

Volumn 3, Issue 3, 2003, Pages 239-241

  Beyth, Rebecca J ^a,b  

^a MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Oral anticoagulant therapy; Quality of life issues; Thromboembolism treatment

Indexed keywords

ANTICOAGULANT AGENT; WARFARIN;

ANTICOAGULATION; BLEEDING; DECISION MAKING; HEART DILATATION; HUMAN; INTERNATIONAL STANDARD UNIT; QUALITY OF LIFE; REVIEW; STROKE;

ADMINISTRATION, ORAL; ANTICOAGULANTS; HEALTH BEHAVIOR; HUMANS; LIFE STYLE; QUALITY OF LIFE;

EID: 0142135456     PISSN: 15289648     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-44459     Document Type: Review

References (19)

1. Guyatt GH. Health status, quality of life, and the individual. JAMA 1994;272:630-631
2. Anderson RJ, Reed WG. Current concepts in treatment of hypertensive urgencies. Am Heart J 1986;111:211-219
3. Pearlman RA, Jonsen A. The use of quality of life consideration in medical decision-making. J Am Geriatr Soc 1985;33:344-352
4. Gelber RD, Lenderking WR, Cotton DJ, et al. Quality of life evaluation in a clinical trial of zidovudine therapy in patients with mildly symptomatic HIV infection. Ann Intern Med 1992;116:961-966
5. Pearlman RA, Uhlmann RF. Quality of life in elderly, chronically ill outpatients. J Gerontol 1991;46:M31-M38
6. Katz S. The science of quality of life. J Chron Dis 1987;40:459-463
7. Gill TM, Feinstein AR. A critical appraisal of the quality of life measurements. JAMA 1994;272:619-626
8. Tsevat J, Eckman MH, McNutt RA, Pauker SG. Warfarin for dilated cardiomyopathy: a bloody tough pill to swallow. Med Decis Making 1989;9:162-169
9. Torrance GW. Utility approach to measuring health-related quality of life. J Chron Dis 1987;40:593-600
10. O'Connor GT, Nease RF. The descriptive epidemiology of the health-state values and utilities. Med Decis Making 1993;13:87-88
11. Gage BF, Cardinalli AB, Owens DK. The effect of stroke and stroke prophylaxis with aspirin or warfarin on quality of life. Arch Intern Med 1996;156:1829-1836
12. Nease RF, Owens DK. A method for estimating the cost-effectiveness of incorporating patient preferences into practice guidelines. Med Decis Making 1994;14:382-392
13. Nease RF, Kneeland T, O'Connor GT, et al. for the Ischemic Heart Disease Patient Outcomes Research Team. Variation in patient utilities for outcomes of the management of chronic stable angina for clinical practice guidelines. JAMA 1995;273:1185-1190
14. Solomon NA, Glick HA, Russo CJ, Lee J, Schulman KA. Patient preferences for stroke outcomes. Stroke 1994;25:320-327
15. Lancaster TR, Singer DE, Sheehan MA, et al. The impact of long-term warfarin therapy on quality of life: evidence from a randomized trial. Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. Arch Intern Med 1991;151:1944-1949
16. Hirsh J. Influence of low-intensity warfarin treatment on patients' perceptions of quality of life. Arch Intern Med 1991;151:1921-1922
17. McCrory DC, Matchar DB, Samsa G, Sanders LL, Pritchett ELC. Physician attitudes about anticoagulation for nonvalvular atrial fibrillation. Arch Intern Med 1995;155:277-281
18. Barcellona D, Contu P, Sorano GG, Pengo V, Marongiu F. The management of oral anticoagulant therapy: the patient's point of view. Thromb Haemostasis 2000;83:49-53
19. Kulinna W, Ney D, Wenzel T, Heene DL, Harenberg J. The effect of self-monitoring the INR on quality of anticoagulation and quality of life. Semin Thrombosis Hemost 1999;25:123-126